This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
Leukemia refers to malignancies of the blood cells as a whole. The kind of leukaemia is determined by the type of cancerous blood cell and how rapidly or slowly it grows. Leukemia develops when the DNA of a single bone marrow cell mutates, making it unable to develop and function normally. The type of leukaemia you have, your age and overall health, and if the leukaemia has spread to other organs or tissues all influence your treatment options. The most prevalent cancer in individuals over 55 is leukaemia, but it is also the most common disease in children under the age of 15.
Lymphoma is a type of cancer that affects the lymphatic system, which is a part of the body's germ-fighting mechanism. Lymph nodes (lymph glands), spleen, thymus gland, and bone marrow are all part of the lymphatic system. All of these locations, as well as other organs throughout the body, can be affected by lymphoma. Lymphoma is relatively treatable, and the prognosis varies depending on the type and stage of lymphoma. One or more of the following treatments may be used: Chemotherapy, radiation therapy, proton therapy, targeted therapy, and surgery are some of the treatments available.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clinical management of sickle cell disease
Lambros K Bourantas, Larnaca General Hospital, Cyprus
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Blood transfusion challenges for one stop perioperative clinic care
Hanadi M Aljedani, King Abdullah Medical City, Saudi Arabia